Topics: Opioids | Stimulants

Predictions that overdose mortality would worsen during the COVID-19 pandemic have unfortunately proven accurate. Recent data outlined in an alert by the CDC show that rates of overdose deaths from opioids and stimulants have accelerated at an alarming rate.

Topics: Buprenorphine | Collaborative care | Free Articles | Methadone | Opioid Use Disorder | Opioids | Pain

Previously, clinicians commonly stopped opioid agonists (methadone and buprenorphine) to simplify pain control during and after surgery. New guidance from the American Society of Addiction Medicine now suggests otherwise.

Topics: Addiction Treatment | Cognitive Behavioral Therapy | Motivational Interviewing | Therapy during medication appointment

Dr. Marienfeld shares strategies of how to turn short clinical appointments meant “only” for medication management into rich therapeutic interactions. She outlines specific techniques drawn from Motivational Interviewing and Cognitive Behavioral Therapy that you can start implementing in office visits right away

Topics: Collaborative care | Detoxification | Harm reduction | Opioid Use Disorder | Opioids | Withdrawal

An emergency department visit can be a “reachable moment” for people with unhealthy opioid use. Here, we review pharmacologic and harm-reduction strategies for use in those settings—and how to advocate for your patients when consulting with emergency clinicians.

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers only. By successfully completing the test you will be awarded a certificate for 1 CME credit.